Mukka Proteins working capital

·FMCG & RetailChart ›
ProfitabilityGrowthCreditLiquidityWorking capitalDividend yieldDuPontCAGR
Per cent unless marked ×
Tap a line for its trendLast 12Mto Jun 2026FY26Mar 2026FY25Mar 2025FY24Mar 2024
221.75×221.75×232.64×136.05×
48.05×48.05×69.84×49.03×
59.68×59.68×65.49×43.78×
210.12×210.12×236.99×141.30×
7.37×6.04×3.20×4.67×
1.07×1.07×1.00×1.47×
−1.95×−1.95×−2.33×−2.02×
−0.97×−0.97×−1.18×−1.43×
Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

MUKKA₹24.68

Mukka Proteins Limited

· FMCG & Retail
₹ CrorePeersNARMADAKSEMcap ₹740 Cr
ProfitabilityGrowthCreditLiquidityWorking CapitalYield AnalysisDuPont
Ratios — % unless marked ×
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Inventory Days (DIO)136.05232.64221.75221.75
Receivable Days (DSO)49.0369.8448.0548.05
Payable Days (DPO)43.7865.4959.6859.68
Cash Conversion Cycle (days)141.30236.99210.12210.12
Working Capital Turnover4.673.206.047.37
Asset Turnover1.471.001.071.07
Cash Conversion (CFO/Net Income)-2.02-2.33-1.95-1.95
CFO/EBITDA-1.43-1.18-0.97-0.97
No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.